Posts tagged LDN
Low-Dose Naltrexone (LDN) Use in Cancer Patients

Naltrexone is classified as an opioid antagonist. Naltrexone blocks opiate drugs from binding to the opioid receptors, which can result in increased endorphin and enkephalin release. This causes a biological response that results in reduced signaling and release of inflammatory substances, nerve cell inflammation and autoimmune mediators. LDN has been studied across a wide variety of autoimmune conditions and cancer diagnosis.

Read More
Supporting Rheumatoid Arthritis and Lupus Patients During the COVID-19 Pandemic

The Medicine Center Pharmacy has hydroxychloroquine in stock to help patients who may be struggling in Ohio to find commonly prescribed therapies for rheumatoid arthritis and lupus. If you have questions about your medication therapy reach out to our pharmacists for a private consultation.

Read More